Topics

Latest "Lung Cancer Research Funding News Magazine Raises Question" News Stories - Page: 20

00:14 EST 20th February 2020 | BioPortfolio

Here are the most relevant search results for "Lung Cancer Research Funding News Magazine Raises Question" found in our extensive news archives from over 250 global news sources.

More Information about Lung Cancer Research Funding News Magazine Raises Question on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Lung Cancer Research Funding News Magazine Raises Question for you to read. Along with our medical data and news we also list Lung Cancer Research Funding News Magazine Raises Question Clinical Trials, which are updated daily. BioPortfolio also has a large database of Lung Cancer Research Funding News Magazine Raises Question Companies for you to search.

Showing "Lung Cancer Research Funding News Magazine Raises Question" News Articles 476–500 of 57,000+

Tuesday 18th February 2020

Abacus Health Products Launches CBD CLINIC™ Massage Therapy Series

Abacus Health Products, Inc. (CSE: ABCS, OTCQX: ABAHF) (“Abacus” or the “Company”) today announced the launch of its new CBD CLINIC Massage Therapy Series, a line of eight new massage oils and creams. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200218005600/en/


News & Views: Most surfaces are rough at many length scales. Simulations show that this characteristic originates at the atomic level in metal-based materials when smooth blocks of these materials are compressed. https://go.nature.com/2SGZubA 

News & Views: Most surfaces are rough at many length scales. Simulations show that this characteristic originates at the atomic level in metal-based materials when smooth blocks of these materials are compressed. https://go.nature.com/2SGZubA 

Proscia® Expands into International Digital Pathology Market to Help Diagnostic Laboratories Keep Pace with Rising Cancer Burden

Industry veteran Arun Ananthapadmanabhan joins as Executive Vice President, Global Growth Proscia, a leading provider of artificial intelligence (AI) enabled digital pathology solutions, has expanded into the international diagnostic pathology market to meet the growing needs of laboratories and cancer patients worldwide. The company has added the leadership of Arun Ananthapadmanabhan as Executi...


Brain Imaging Offers New Insight Into Antisocial Behavior

Antisocial behavior that starts in childhood and persists into adulthood is associated with structural brain differences involving reduced surface area and cortical thickness. Medscape Medical News

Xencor to Host Fourth Quarter and Full Year 2019 Financial Results Webcast and Conference Call on February 24, 2020

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced that it will release fourth quarter and full year 2019 financial results after the market closes on Monday, February 24, 2020. Xencor management will host a webcast and conference call the same day at 4:30 p.m. E...

Gut Microbiome Improved on Mediterranean Diet, Linked to Healthy Aging

An international team of investigators, led by researchers at the University of Cork, set out to determine the effects of the Mediterranean diet on older populations. Amazingly, the five-country study found that eating a Mediterranean diet for a year boosts the types of gut bacteria linked to “healthy” aging while reducing those associated with harmful inflammation in older people. The post Gu...

Alzheimer’s Disease and Tau Tangle Proteinopathies Linked to Protein that Prevents Tau Clearance

Studies by researchers at University of South Florida Health (USF Health) Morsani College of Medicine have found that the oligomerized form of a protein known as β-arrestin2 increases the accumulation of the neurotoxic tau tangles that cause several forms of dementia, by interfering with the process that cells use to remove excess tau from the brain. The post Alzheimer’s Disease and Tau Tan...

MERS Coronavirus Disease Blocked by Remdesivir in Monkeys

Remdesivir is a drug with broad antiviral activity. Researchers at the National Institute of Allergy and Infectious Diseases (NIAID) report new data suggesting that it may be a promising treatment against MERS coronavirus (MERS-CoV). Remdesivir reduced the severity of disease, virus replication, and damage to the lungs when administered to infected monkeys. It may also be effective against other, ...

Bridge Connector and Skedulo Announce Partnership to Automate Complex Scheduling and Patient Care Workflows for Health Care Providers

Mobile workforce optimizer leveraging leading health care data integration expert’s capabilities to grow its footprint in health care Bridge Connector, a technology company offering data-driven workflow automation to solve health IT interoperability challenges, today announced a partnership with

Clinical Ink Announces Addition of New Module to Their Lumenis™ eSource Ecosystem

Clinical Ink, a global clinical trial technology company, announces the addition of a new component to their Lumenis™ eSource Ecosystem. With the addition of eConsent, Clinical Ink’s Lumenis platform expands further, providing purpose-built solutions for your protocol and anytime, anywhere access to study data. This press release features multimedia. View the full release here:

Cotiviti CEO Emad Rizk, M.D., to Speak at UCI Health Care Forecast Conference

Leading physician executive to address digital transformation in healthcare Emad Rizk, M.D., chairman, president, and chief executive officer of Cotiviti, has been selected as a speaker at the

Endologix, Inc. to Present at the SVB Leerink Global Healthcare Conference

Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that Vaseem Mahboob, Chief Financial Officer, will present at the 9th Annual SVB Leerink Global Healthcare Conference at 3:00 p.m. ET on Wednesday, February 26, 2020 in New York, NY. A live webcast of the presentation will be accessible through the “Investors” section of t...

Inovi Fertility Launches State-of-the-Art Fertility Lab in Central Houston Location

New Clinic Adds Integrated Laboratory to Full Suite of Fertility Services (PRWEB) February 18, 2020 Inovi Fertility & Genetics Institute, a new boutique fertility clinic located in the heart of Houston, TX, will be launching a state-of-the-art laboratory in February as part of its advanced in vitro fertilization (IVF) and andrology treatment services. “We are excited to provide the thrivin...

Lee Health Partners with Trellis Rx to Offer Integrated Specialty Pharmacy Services

Lee Health announced today that it will begin offering clinic-based specialty pharmacy services in February. Specialty pharmacies provide additional support and education for patients suffering from chronic conditions, and the opening of the Lee Health Specialty Pharmacy advances Lee Health’s goal of being active partners with patients to help them along their health care journey. The Lee Healt...

Lineage Cell Therapeutics to Present New Data From OpRegen® and Vision Restoration Programs at the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2020)

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that updated results from a Phase I/IIa study of its lead product candidate,

Saama’s Growth Strategy Continues with Addition of Jonathan Burr and Gregory Simpson to Leadership Team

Saama Technologies, Inc. (“Saama”), the number one AI clinical analytics platform company, announced today that it recently expanded its leadership team to include life science technology expert Jonathan Burr as Senior Vice President of Clinical Platform Strategy, and technology marketing leader Gregory T. Simpson as Vice President, Head of Marketing. Jonathan is responsible for growing clien...

Eureka Therapeutics to Present at the CAR-TCR Summit Europe

Eureka Therapeutics, Inc., a clinical stage biotechnology company developing novel T cell therapies to treat solid tumors, today announced that its Director of Strategy and Business Development, Dr. Jingyi Xiang, will be presenting at CAR-TCR Summit Europe being held at the Novotel London West, London, United Kingdom on February 25, 2020.

BioVentrix Announces Gregg Stone, MD, as Co-Principal Investigator for ALIVE Pivotal Trial of Transcatheter Device for Heart Failure

BioVentrix, Inc., a pioneer of technologies and procedures for the less invasive treatment of heart failure (HF), today announced that Gregg Stone, MD, of New York’s Mount Sinai Health System has signed on to the pivotal

Ventas Becomes First S&P 500 REIT Signatory to the United Nations Global Compact

The Company also signs the United Nations Women’s Empowerment Principles Building on the momentum of a strong year of environmental, social and governance (ESG) activity, Ventas, Inc. (NYSE: VTR) announced today that it is the first S&P 500 REIT to become a signatory to the United Nations Global Compact (“UNGC”). Ventas joins more than 10,000 companies around the world including real e...

GRAIL Initiates First Interventional Study Using its Multi-Cancer Early Detection Test to Guide Clinical Care

-- The PATHFINDER Study will Return GRAIL’s Test Results to Providers for the First Time -- -- First Participants Successfully Enrolled -- -- FDA Approves IDE for GRAIL’s Test -- GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced the initiation of the PATHFINDER Study. A prospective, multi-center study, PATHFINDER marks the fi...

Personalis to Participate at the Cowen 40th Annual Health Care Conference

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that company management will participate at the upcoming Cowen 40th Annual Health Care Conference. John West, Chief Executive Officer, will be presenting on Wednesday, March 4, 2020 at 8:40 a.m. Eastern Time at the Boston Marriott Copley Place hotel in Boston. About Personalis, Inc. Personalis, Inc. i...

Zydus Cadila to launch research for COVID-19 vaccine

Zydus Cadila unveiled plans for its accelerated research program to develop a vaccine for the novel coronavirus COVID-19 in c -More- 

AquaBounty's common stock offering raises $15.5M

AquaBounty Technologies announced that the sale of its common stock offering raised an estimated $15.5 million after 10,350,0 -More- 

Binaural beats synchronize brain activity, don’t affect mood

An auditory illusion thought to synchronize brain waves and alter mood is no more effective than other sounds, according to research in adults recently published in eNeu

Hammer-News!: Nun zündet wirklich die nächste Stufe der 500%-Rakete

Anzeige / Werbung+++ Soeben veröffentlichte Hammer News +++ 8 Krebsmedikamente in Entwicklung +++ Gefördert von der EU +++ Bauchspeicheldrüse, Gehirn, Auge, Blut, Lunge +++ Partnerschaft mit drei N...


Quick Search

News Quicklinks